Inkwell Capital’s Elevance Health ELV Stock Holding History

Inkwell Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$949K	Sell	3,242 -23	-0.7%	-$7.56K	0.97%	29
2025 Q4	$1.14M	Sell	3,265 -14	-0.4%	-$4.73K	1.16%	28
2025 Q3	$1.06M	Sell	3,279 -57	-2%	-$17.7K	1.08%	28
2025 Q2	$1.3M	Sell	3,336 -40	-1%	-$16.1K	1.39%	25
2025 Q1	$1.47M	Buy	3,376 +136	+4%	+$54.6K	1.6%	26
2024 Q4	$1.2M	Buy	+3,240	New	+$1.36M	1.28%	25

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Inkwell Capital's ELV Position: Q1 2026 in Review

Inkwell Capital reduced its Elevance Health (ELV) stake by 0.7% in Q1 2026, selling an estimated $7.56K and leaving 3,242 shares worth $949K. The position accounts for 0.97% of the portfolio, ranked #29.

Inkwell Capital first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.47M in Q1 2025. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Inkwell Capital held 3,242 shares of Elevance Health worth $949K as of Q1 2026.
Inkwell Capital sold 23 Elevance Health shares in Q1 2026, an estimated $7.56K.
Elevance Health made up 0.97% of Inkwell Capital's portfolio in Q1 2026, its #29 holding.
Inkwell Capital first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
Inkwell Capital's Elevance Health position peaked at $1.47M in Q1 2025.
1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Inkwell Capital's 13F filing for Q1 2026, filed 15 May 2026.